TE_194
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | L2b_3end |
---|---|
TE superfamily | L2 |
TE class | LINE |
Gene | AKR7A2 |
Class | Chimeric |
Coding | Non-coding, Other |
Tumor-specific score | 0.69 |
Counts of samples | TCGA_tumor:382; TCGA_normal:32; GTEx:594 |
TSS | chr1(-):19311131 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_194.1 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19304366,19304386,19306018,19306147,19307002,19307101,19307314,19307410,19308158,19308262,19308455,19308642,19311080,19311132 |
teRNA_194.2 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19304366,19304386,19306018,19306147,19307002,19307101,19307314,19307410,19308455,19308642,19311080,19311132 |
teRNA_194.3 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19304366,19304386,19306018,19306147,19308158,19308262,19308455,19308642,19311080,19311132 |
teRNA_194.4 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19308242,19308262,19308455,19308642,19311080,19311132 |
teRNA_194.5 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19304366,19304386,19306018,19306147,19307002,19307101,19307314,19307410,19308158,19308262,19308455,19308947,19311080,19311132 |
teRNA_194.6 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19304366,19304386,19306018,19306147,19307002,19307101,19307314,19307410,19308455,19308947,19311080,19311132 |
teRNA_194.7 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19304366,19304386,19306018,19306147,19308158,19308262,19308455,19308947,19311080,19311132 |
teRNA_194.8 | AKR7A2 | Chimeric | Other | MALIGHLTIPFSLQVKIATKANPWDGKSLKPDSVRSQLETSLKRLQCPQVDLFYLHAPDHGTPVEETLHACQRLHQEGKFVELGLSNYASWEVAEICTLCKSNGWILPTVYQGAC* | chr1(-):19304366,19304386,19306018,19306147,19307002,19307101,19308158,19308262,19308455,19308947,19311080,19311132 |
teRNA_194.9 | AKR7A2 | Chimeric | Non-coding | Non-coding | chr1(-):19308242,19308262,19308455,19308947,19311080,19311132 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.